Showing results (751-760 of 8,523) with videos related to

Sort By:
Pageof 853
Alimentary Pharmacology & Therapeutics|November 9, 2002
Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressureT W Evans
Alimentary Pharmacology & Therapeutics|January 22, 2003
Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxibR H Hunt, S Harper, P Callegari, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2003
Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pHM F Vela, R Tutuian, P O Katz, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2003
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycinH Kawabata, Y Habu, H Tomioka, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2003
Retained common bile duct stones: a comparison between biliary stenting and complete clearance of stones by electrohydraulic lithotripsyC-K Hui, K-C Lai, M Ng, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2002
Efficacy of enzyme immunoassay for the detection of Helicobacter pylori antigens in frozen stool specimens: local validationY K Yee, K T Yip, T L Que, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2002
Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel diseaseA Ansari, C Hassan, J Duley, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2002
Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remissionO A Paoluzi, R Pica, A Marcheggiano, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2002
Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's diseaseB R Yacyshyn, C Barish, J Goff, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2002
Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?J P Gisbert, E A Jones, J M Pajares, et al.
Pageof 853